About this item

"Autonomous is to biotech and AI what Neuromancer was to the Internet." -- Neal Stephenson

"Something genuinely and thrillingly new in the naturalistic, subjective, paradoxically humanistic but non-anthropomorphic depiction of bot-POV -- and all in the service of vivid, solid storytelling." -- William Gibson

When anything can be owned, how can we be free

Earth, 2144. Jack is an anti-patent scientist turned drug pirate, traversing the world in a submarine as a pharmaceutical Robin Hood, fabricating cheap scrips for poor people who can't otherwise afford them. But her latest drug hack has left a trail of lethal overdoses as people become addicted to their work, doing repetitive tasks until they become unsafe or insane.

Hot on her trail, an unlikely pair: Eliasz, a brooding military agent, and his robotic partner, Paladin. As they race to stop information about the sinister origins of Jack's drug from getting out, they begin to form an uncommonly close bond that neither of them fully understand.

And underlying it all is one fundamental question: Is freedom possible in a culture where everything, even people, can be owned?



About the Author

Annalee Newitz

Annalee Newitz writes about the intersection of science, technology and culture. Currently she is the tech culture editor at Ars Technica, and previously she was the founding editor of io9, and the editor-in-chief of Gizmodo. She has also written for publications including Wired, Popular Science, the New Yorker, the Atlantic, Slate, Washington Post, Smithsonian Magazine, and more. She has published short stories in Lightspeed, Shimmer, Apex, and Technology Review's Twelve Tomorrows.

She was the recipient of a Knight Science Journalism Fellowship at MIT, worked as a policy analyst at the Electronic Frontier Foundation, and has a Ph.D. in English and American Studies from UC Berkeley.

Learn more at AnnaleeNewitz.com or follow her on Twitter @annaleen



Read Next Recommendation

Discuss with your friends


Report incorrect product information.